Asaf Wasserman
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Sepsis Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
- Pneumonia and Respiratory Infections
Papers in
-
- Antibiotic Use and Resistance 2
- Epidemiology 17
- Sepsis Diagnosis and Treatment 13
- Adipokines, Inflammation, and Metabolic Diseases 6
- Co-authors
- Tal LevinsonShlomo BerlinerShani Shenhar‐TsarfatyOri RogowskiItzhak ShapiraDavid ZeltserHanan Guzner‐GurIlana Goldiner
- Journals
- Clinica Chimica Acta (5 papers)Medicine (3 papers)Journal of Clinical Medicine (2 papers)International Journal of Molecular Sciences (2 papers)Infection (2 papers)
- Partner nations
- IsraelCzechiaUnited Kingdom
In The Last Decade
Asaf Wasserman
28 papers receiving 356 citations
Peers
Comparison fields: 5 of 82
- Infectious Diseases 106
- Epidemiology 154
- Nephrology 30
- Critical Care and Intensive Care Medicine 18
- Emergency Medicine 28
Countries citing papers authored by Asaf Wasserman
This map shows the geographic impact of Asaf Wasserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asaf Wasserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asaf Wasserman more than expected).
Fields of papers citing papers by Asaf Wasserman
This network shows the impact of papers produced by Asaf Wasserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asaf Wasserman. The network helps show where Asaf Wasserman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Asaf Wasserman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 7 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 11 | |
| 14 | 2019 | 4 | |
| 15 | 2019 | 8 | |
| 16 | 2019 | 11 | |
| 17 | 2019 | 17 | |
| 18 | 2019 | 42 | |
| 19 | 2018 | 11 | |
| 20 | 2009 | 26 |
About Asaf Wasserman
Asaf Wasserman is a scholar working on Applied Microbiology and Biotechnology, Epidemiology, Family Practice, Nephrology and Critical Care and Intensive Care Medicine, having authored 30 papers that have together received 364 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (13 papers), Streptococcal Infections and Treatments (8 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), COVID-19 Clinical Research Studies (5 papers), Blood properties and coagulation (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Antibiotic Use and Resistance (2 papers) and Healthcare cost, quality, practices (2 papers). The work is most often cited by research in Infectious Diseases (106 citations), Epidemiology (154 citations), Nephrology (30 citations), Critical Care and Intensive Care Medicine (18 citations) and Emergency Medicine (28 citations). Asaf Wasserman has collaborated with scholars based in Israel, Czechia and United Kingdom. Frequent co-authors include Tal Levinson, Shlomo Berliner, Shani Shenhar‐Tsarfaty, Ori Rogowski, Itzhak Shapira, David Zeltser, Hanan Guzner‐Gur, Ilana Goldiner, Tomer Ziv‐Baran and Ben Boursi. Their work appears in journals such as Clinica Chimica Acta, Medicine, Journal of Clinical Medicine, International Journal of Molecular Sciences and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.